Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy Study 2
| Status: | Completed |
|---|---|
| Conditions: | Healthy Studies |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 18 - 40 |
| Updated: | 4/4/2019 |
| Start Date: | October 2008 |
| End Date: | October 2008 |
Retention of an Orally Administered Investigational Device vs Commerical Device in the Oral Cavity and Oropharynx of Healthy Human Male Volunteers
Single usage, open label study in up to 40 adult healthy males. Eligible subjects will
receive a single usage of the investigational or commercial device. Retention of the
radiolabeled device will be monitored using gamma scintigraphy.
receive a single usage of the investigational or commercial device. Retention of the
radiolabeled device will be monitored using gamma scintigraphy.
Inclusion Criteria:
- Refrain from nasal, throat, or lung inhalants and exercise for 24 hour prior to the
test
- Are able to tolerate the procedure and
- Be generally healthy
Exclusion Criteria:
- Have history of allergy or hypersensitivity to the study ingredients
- Major diseases
- Taking medication regularly
- Radiation exposure recently
We found this trial at
1
site
Click here to add this to my saved trials
